Abstract
Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Current Genomics
Title: Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family
Volume: 6 Issue: 6
Author(s): C. A. Spek, M. V. Zoelen, S. H. Diks and M. P. Peppelenbosch
Affiliation:
Keywords: Chordates, cytokines receptors, tissue factor, prokariotic secretion system 2
Abstract: Already in the 19th century, it was accepted that tissues display clot-promoting activity. The awareness that a single protein was accountable for this pro-coagulant effect led to the detection of tissue factor (tissue factor), but for many years it was thought that tissue factor activity was restricted to the activation of an auxiliary pathway that had little biological significance. Today tissue factor is recognised to be the primary biological initiator of the coagulation cascade. In silico studies have highlighted the high degree of structural similarity of tissue factor with the super family of interferon receptors. The cytokine class II receptor family has probably evolved from an ancient gene coding for a pre-eukaryotic extracellular protein. Tissue factor evolved from this protein and matching sequences are found in invertebrates, especially insects. From tissue factor, the other receptors evolved. Strikingly, the common evolutionary origin of tissue factor and cytokine receptors is reflected in identical signalling. The evolutionary origin of tissue factor is the subject of the present review.
Export Options
About this article
Cite this article as:
Spek A. C., Zoelen V. M., Diks H. S. and Peppelenbosch P. M., Functional Evolution of Tissue Factor, the Archetype of the Cytokine Receptor Family, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483025
DOI https://dx.doi.org/10.2174/138920205774483025 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects
Current Pharmaceutical Design Multidisciplinary Treatment of Early Stage Endometrial Cancer
Anti-Cancer Agents in Medicinal Chemistry Molecular Genetics of Pigmentation in Domestic Animals
Current Genomics Immune Mechanism, Aging, Season and Diseases: Modulatory Role of Melatonin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cellular Signaling in Cartilage Tissue Engineering
Current Signal Transduction Therapy Carotenoids of Microalgae Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Integration and Querying of Heterogeneous Omics Semantic Annotations for Biomedical and Biomolecular Knowledge Discovery
Current Bioinformatics Interleukin-2 Immunotherapy and AIDS-Related Cytomegalovirus Retinitis
Current HIV Research Yeast Genomics and Drug Target Identification
Combinatorial Chemistry & High Throughput Screening Anti-NMDA Receptor Encephalitis in Psychiatry
Current Psychiatry Reviews Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms
Current Cancer Drug Targets Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Elastin-Like Recombinamers As Smart Drug Delivery Systems
Current Drug Targets Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design Recent Patents on the Baculovirus Systems
Recent Patents on Biotechnology Design and Endpoints of Clinical and Translational Trials in Advanced Colorectal Cancer. A Proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD)
Reviews on Recent Clinical Trials The Rb Pathway and Cancer Therapeutics
Current Drug Targets Epigenetics Changes in the RA Synovium
Current Rheumatology Reviews Plasma Rich in Growth Factors Enhances Wound Healing and Protects from Photo-oxidative Stress in Dermal Fibroblasts and 3D Skin Models
Current Pharmaceutical Biotechnology Artificial Intelligence (AI) in Drugs and Pharmaceuticals
Combinatorial Chemistry & High Throughput Screening